These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 33629861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y, Takeuchi S, Matsui K, Amidon GE, Amidon GL.
    Eur J Pharm Sci; 2015 Aug 30; 76():203-12. PubMed ID: 25978875
    [Abstract] [Full Text] [Related]

  • 3. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H, Löbenberg R.
    Eur J Pharm Sci; 2006 Sep 30; 29(1):45-52. PubMed ID: 16815694
    [Abstract] [Full Text] [Related]

  • 4. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
    Pawar G, Wu F, Zhao L, Fang L, Burckart GJ, Feng K, Mousa YM, Al Shoyaib A, Jones MC, Batchelor HK.
    AAPS J; 2023 Jun 29; 25(4):67. PubMed ID: 37386339
    [Abstract] [Full Text] [Related]

  • 5. Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug.
    Danielak D, Gajda M, Bołtromiuk T, Sulikowska K, Kubiak B, Romański M.
    Eur J Pharm Biopharm; 2024 Jul 29; 200():114341. PubMed ID: 38795785
    [Abstract] [Full Text] [Related]

  • 6. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N, Kuminek G, Al-Gousous J, Sperry DC, Greenwood DE, Waltz NM, Amidon GL, Ziff RM, Amidon GE.
    Mol Pharm; 2021 Sep 06; 18(9):3326-3341. PubMed ID: 34428047
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
    Henze LJ, Koehl NJ, Jansen R, Holm R, Vertzoni M, Whitfield PD, Griffin BT.
    Eur J Pharm Biopharm; 2020 Sep 06; 154():116-126. PubMed ID: 32580049
    [Abstract] [Full Text] [Related]

  • 9. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2016 Apr 06; 101():103-11. PubMed ID: 26873006
    [Abstract] [Full Text] [Related]

  • 10. Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modeling.
    Segregur D, Mann J, Moir A, Karlsson EM, Dressman J.
    Eur J Pharm Sci; 2021 Mar 01; 158():105656. PubMed ID: 33253885
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y, Kostewicz ES, Sheu MT, Dressman JB.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [Abstract] [Full Text] [Related]

  • 12. A physiologically-based drug absorption modeling for orally disintegrating tablets.
    Kambayashi A, Kiyota T.
    Eur J Pharm Biopharm; 2020 Jul 01; 152():1-9. PubMed ID: 32371153
    [Abstract] [Full Text] [Related]

  • 13. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M, Przyklenk KH, Richtberg A, Baumann W, Dressman JB.
    Eur J Pharm Biopharm; 2014 Nov 01; 88(3):795-806. PubMed ID: 25195981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study.
    Kuminek G, Salehi N, Waltz NM, Sperry DC, Greenwood DE, Hate SS, Amidon GE.
    Mol Pharm; 2023 Jan 02; 20(1):147-158. PubMed ID: 36367432
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.